Yoo Je-Ok, Kwak Seo-Young, An Hyun-Ju, Bae In-Hwa, Park Myung-Jin, Han Young-Hoon
Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Nowon-gil 75, Nowon-gu, Seoul 139-706, Republic of Korea.
Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Nowon-gil 75, Nowon-gu, Seoul 139-706, Republic of Korea; Laboratory of Biochemistry, School of Life Sciences and Biotechnology, Korea University, Anam-ro 145, Seongbuk-gu, Seoul 136-701, Republic of Korea.
Biochim Biophys Acta. 2016 Jul;1863(7 Pt A):1601-11. doi: 10.1016/j.bbamcr.2016.04.016. Epub 2016 Apr 18.
Epithelial-mesenchymal transition (EMT) is essential for increased invasion and metastasis during cancer progression. Among the candidate EMT-regulating microRNAs that we previously identified, miR-181b-3p was found to induce EMT in MCF7 breast cancer cells, as indicated by an EMT-characteristic morphological change, increased invasiveness, and altered expression of an EMT marker. Transfection with a miR-181b-3p inhibitor reduced the expression of mesenchymal markers and the migration and invasion of highly invasive breast cancer cells. miR-181b-3p induced the upregulation of Snail, a master EMT inducer and transcriptional repressor of E-cadherin, through protein stabilization. YWHAG was identified as a direct target of miR-181b-3p, downregulation of which induced Snail stabilization and EMT phenotypes. Ectopic expression of YWHAG abrogated the effect of miR-181b-3p, including Snail stabilization and the promotion of invasion. In situ hybridization and immunohistochemical analyses indicated that YWHAG expression was inversely correlated with the expression of miR-181b-3p and Snail in human breast cancer tissues. Furthermore, transfection with miR-181b-3p increased the frequency of metastatic nodule formation in the lungs of mice in experimental metastasis assays using MDA-MB-231 cells. Taken together, our data suggest that miR-181b-3p functions as a metastasis activator by promoting Snail-induced EMT, and may therefore be a therapeutic target in metastatic cancers.
上皮-间质转化(EMT)在癌症进展过程中对于增强侵袭和转移至关重要。在我们之前鉴定出的候选EMT调节性微小RNA中,发现miR-181b-3p可诱导MCF7乳腺癌细胞发生EMT,这表现为EMT特征性的形态变化、侵袭性增加以及EMT标志物表达改变。用miR-181b-3p抑制剂转染可降低间充质标志物的表达以及高侵袭性乳腺癌细胞的迁移和侵袭能力。miR-181b-3p通过蛋白稳定作用诱导Snail上调,Snail是EMT的主要诱导因子和E-钙黏蛋白的转录抑制因子。YWHAG被鉴定为miR-181b-3p的直接靶标,其下调可诱导Snail稳定并导致EMT表型。YWHAG的异位表达消除了miR-181b-3p的作用,包括Snail稳定和侵袭促进作用。原位杂交和免疫组化分析表明,在人乳腺癌组织中,YWHAG的表达与miR-181b-3p和Snail的表达呈负相关。此外,在使用MDA-MB-231细胞进行的实验性转移分析中,用miR-181b-3p转染增加了小鼠肺部转移结节形成的频率。综上所述,我们的数据表明miR-181b-3p通过促进Snail诱导的EMT发挥转移激活剂的作用,因此可能是转移性癌症的治疗靶点。